News Image

KILL Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval

Provided By Business Wire

Last update: May 23, 2025

Agilent Technologies Inc. requests that their press release NewsItemId: 20250324197742 issued March 24, 2025 “Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval” be removed.

AGILENT TECHNOLOGIES INC

NYSE:A (12/17/2025, 7:00:00 PM)

After market: 136.66 0 (0%)

136.66

-2.53 (-1.82%)



Find more stocks in the Stock Screener

Follow ChartMill for more